Senolytic Report may collect information you voluntarily submit and basic analytics data used to understand site performance. We do not sell medical information. If third-party analytics, advertising or email tools are added, this policy must be updated to name those providers and explain their data practices.
Last updated: August 10, 2026.
Research references
Scope of this policy
This privacy notice describes information that may be collected through visits, analytics, server logs, contact messages, and other site functions. It should reflect the actual technology deployed on the live site.
Information visitors provide
Visitors may voluntarily provide information through email or contact channels. The site should collect only what is reasonably necessary for the purpose stated.
Technical data
Web servers and analytics services can collect browser type, device information, referring pages, timestamps, approximate location, and page interactions.
Cookies
Cookies and similar technologies may support functionality, analytics, attribution, and advertising. If new third-party services are introduced, this policy and any consent mechanism should be reviewed.
External sites
The site links to manufacturers, research databases, and commercial websites. Those third parties operate under their own privacy practices.
Retention
Information should not be kept longer than reasonably necessary for operational, legal, security, or record-keeping purposes.
Security
No website can promise perfect security. Reasonable safeguards should be used, and the site should avoid collecting sensitive information it does not need.
Policy updates
This policy may change as analytics, advertising, forms, or other site functions change. The published version should remain consistent with actual practice.
Update trigger 1
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 2
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 3
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 4
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 5
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 6
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 7
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 8
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 9
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 10
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 11
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 12
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 13
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.
Update trigger 14
For Privacy Policy, the conclusion should remain open to revision. New human studies, formula changes, updated COAs, price changes, and newly disclosed testing can all alter the commercial recommendation. The useful goal is not to create a permanent winner, but to make the comparison transparent enough that readers can see why the conclusion was reached and what evidence would change it.